Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice

Journal of Leukocyte Biology

Volumn 67, Issue 1, 2000, Pages 90-96

  Tagawa, Yoh Ichi ^c   Matthys, Patrick ^c   Heremans, Hubertine ^c   Dillen, Chris ^c   Zaman, Zahur ^a   Iwakura, Yoichiro ^c   Billiau, Alfons ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c NONE

Author keywords

Interferon hepatic injury

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEPATITIS; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0033979047     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.1.90     Document Type: Article

References (23)

1. Tiegs, G., Hentschel, J., Wendel, A. (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203.
2. Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., Fujiwara, H. (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin-6. J. Exp. Med. 179, 1529-1537.
3. Gantner, F., Leist, M., Kusters, S., Vogt, K., Volk, H. D., Tiegs, G. (1996) T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp. Cell. Res. 229, 137-146.
4. Gantner, F., Leisl, M., Lohse, A. W., Germann, P. G., Tiegs, G. (1995) Concanavalin A-induced T-cell-mediated hepatic injury in mice: the rule of tumor necrosis factor. Hepatology 21, 190-198.
5. Kusters, S., Gantner, F., Kunstle, G., Tiegs, G. (1996) Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterol. 111, 462-471.
6. Mizuhara, H., Uno, M., Seki, N., Yamashita, M., Yamaoka, M., Ogawa, T., Kaneda, K., Fujii, T., Senoh, H., Fujiwara, H. (1996) Critical involvement of interferon-γ in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatol. 23, 1608-1615.
7. -/- mice. J. Immunol. 159, 1418-1428.
8. Louis, H., Le Moine, O., Peny, M. O., Quertinmont, E., Fokan, D., Goldman, M., Deviere, J. (1997) Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatol. 25, 1382-1389.
9. Seino, K., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K., Yagita, H. (1997) Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterol. 112, 1315-1322.
10. Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K. R., Tannahill, C. L., Solorzano, C. C., Norman, J., Denham, W., Salzler, C., MacKay, S. L., Moldawer, L. L. (1998) Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis. J. Immunol. 160, 4082-4089.
11. Tagawa, Y., Kakuta, S., Iwakura, Y. (1998) Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-iduced hepatitis. Eur. J. Immunol. 28, 4105-4113.
12. Libert, C., Brouckaert, P., Fiers, W. (1994) Protection by αl-acid glycoprotein against tumor necrosis factor-induced lethality. J. Exp. Med. 180, 1571-1575.
13. Libert, C., Van Molle, W., Brouckaert, P., Fiers, W. (1996) αl-antitrypsin inhibits the lethal response to TNF in mice. J. Immunol. 157, 5126-5129.
14. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., Kohler, G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
15. Vink, A., Coulie, P., Warnier, G., Renauld, J. C., Stevens, M., Donckers, D., Van Snick, J. (1990) Mouse plusmacytoma growth in vivo: enhancement by interleukin 6 (II,-6) and inhibition by antibodies directed against II,-6 or its receptor. J. Exp. Med. 172, 997-1000.
16. Starnes, H. F., Jr., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., Abrams, J. S. (1990) Anti-IL,-6 monoclonal antibodies protect against lethal Echerichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145, 4185-4191.
17. Heremans, H., Dillen. C., Put, W., Van Damme, J., Billiau, A. ( 1992) Protective effect of anti-interleukin (IL,)-6 antibody against endotoxin, associated with paradnxicalh increased IL-6 levels. Eur. J. Immunol. 22, 2395-2401.
18. Chomezynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
19. Chiu, C. P., Moulds, C., Coffman, R. L., Rennick, D., Lee, F. (1988) Multiple biological activities are expressed by a mouse inlerleukin-6 cDNA clone isolated from bone marrow stromal cells. Proc. Natl. Acad. Sci. USA 85, 7099-7103.
20. Martens, E., Dillen, C., Put, W., Heremans, H., Van Damme, J., Billiau, A. (1993) Increased circulating interleukin-6 (IL-6) activity in endotoxin challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur. J. Immunol. 23, 2026-2029.
21. Matthys, P., Froyen. G., Huang, S., Sobis, H., Van Damme, J., Aguet, M., Billiau, A. (1995) Interferon-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: Protective role of endogenous nitric oxide. J. Immunol. 155, 3823-3829.
22. Lu, Z. Y., Brochier, J., Wijdenes, J., Brailly, H., Bataille R., Klein, B. (1992) High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur. J. Immunol. 22, 2819-2824.
23. Yoshizawa, K. I., Naruto, M., Ida, N. (1996) Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock. J. Interferon Cytokine Res. 16, 995-1000.